The ”What This Means” segment is now available here.

Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across IndiaDifferentiated PH1 payload ...

Like the spliceosome, the ribosome undergoes conformational changes to perform chemical catalysis. Such conformational dynamics can often be an impediment to understanding structure and function.

Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of immune system through multiple mechanisms India represents a key ...